More and more AI algorithms are being trained to learn, think and act like a human physician. What does this mean for the future of cardiovascular imaging as time goes on?

This is the second time in a matter of weeks the FDA has approved an RDN system for uncontrolled hypertension. The SCAI issued a statement about this trend, calling it a “game-changer for both interventional cardiology and the treatment of hypertension."

While the therapy has been successfully tested on animals in the past, this study represents the first time it has been used on humans.

Researchers evaluated two techniques for predicting PPM after TAVR, comparing them to how cardiologists typically check for PPM in day-to-day practice. 

Hospital readmissions, ER visits and major complications were all less likely when TAVR patients used a smartphone app to assist with their recovery. 

The company had good news to share about its highly anticipated PFA offering.